VD/VDR
| 货号 | 产品名 | CAS号 | 信息 |
|---|---|---|---|
| FB10672 | Vitamin D4 | 511-28-4 | Vitamin D4 is the active analogue of Vitamin D. |
| FB10520 | Vitamin D3 | 67-97-0 | Vitamin D3, the inactive precursor of calcitriol, is effective in metabolic activation and can be used in treatment of osteoporosis. |
| FB00913 | Vitamin D2 | 50-14-6 | Vitamin D2 selectively inhibits mammalian DNA polymerase A (pol A) with IC50 of 123 mM. |
| FB06963 | Tacalcitol Monohydrate | 93129-94-3 | Tacalcitol promotes normal bone development by regulating calcium. |
| FB09646 | Tacalcitol | 57333-96-7 | Tacalcitol promotes normal bone development by regulating calcium. |
| FB09257 | Seocalcitol | 134404-52-7 | Seocalcitol is a vitamin D analog, binds vitamin D receptor protein from human osteosarcoma MG-63 cells with Kd of 0.27 nM. |
| FB06124 | Secalciferol | 55721-11-4 | Secalciferol is a metabolite of Vitamin D, a possibly anti-inflammatory steroid which is involved in bone ossification. |
| FB08005 | Paricalcitol | 131918-61-1 | Paricalcitol is a vitamin D receptor agonist, used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. |
| FB02696 | MC1046 | 126860-83-1 | MC1046 is an impurity of calcipotriol, a ligand of VDR-like receptors. |
| FB08975 | Maxacalcitol | 103909-75-7 | Maxacalcitol is non-calcemic vitamin D3 analog and ligand of VDR-like receptors. |
| FB03420 | Lexacalcitol | 131875-08-6 | Lexacalcitol is over 100 times more active than 1alpha, 25-dihydroxyvitamin D3 [1alpha,25-(OH)2D3], as judged by in vitro antiproliferative and cell differentiating assays. |
| FB02278 | Impurity of Calcipotriol | 112875-61-3 | Impurity of calcipotriol is an impurity of calcipotriol |
| FB06859 | Impurity C of Calcitriol | 86307-44-0 | Impurity C of calcitriol is an impurity of calcitriol, and calcitriol is the hormonally active form of vitamin D, an active metabolite of vitamin D3 that activates the vitamin D receptor (VDR). |
| FB06301 | Impurity C of Alfacalcidol | 82266-85-1 | Impurity C of alfacalcidol is an impurity of alfacalcidol, a non-selective VDR activator medication. |
| FB06236 | Impurity B of Calcitriol | 66791-71-7 | Impurity B of calcitriol is an impurity of calcitriol, and calcitriol is the hormonally active form of vitamin D, an active metabolite of vitamin D3 that activates the vitamin D receptor (VDR). |
| FB01724 | Falecalcitriol | 83805-11-2 | Falecalcitriol is an analog of calcitriol with a higher potency both in vivo and in vitro systems, and longer duration of action in vivo. |
| FB01288 | Ercalcitriol | 60133-18-8 | Ercalcitriol is an active metabolite of vitamin D2. |
| FB07004 | Ercalcidiol | 21343-40-8 | Ercalcidiol is a metabolite of vitamin D2, is regarded as an indicator of vitamin D nutritional status. |
| FB11040 | Elocalcitol | 199798-84-0 | Elocalcitol is a vitamin D3 analog having agonistic activities at vitamin D receptor (VDR). |
| FB01948 | Eldecalcitol | 104121-92-8 | Eldecalcitol, an analog of vitamin D, is a drug used for the treatment of osteoporosis. |
| FB17722 | DPI-08 | 1446698-05-0 | DPI-08 is a stapled peptide targeting VDR–coactivator interactions. It demonstrated strong activity with IC50 value of 3.2μM evaluated by a receptor cofactor assay system. |
| FB00914 | Doxercalciferol | 54573-75-0 | Doxercalciferol is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease. |
| FB07547 | Calcitriol | 32222-06-3 | Calcitriol is a vitamin D receptor agonist with IC50 of 0.4 nM. |
| FB06260 | Calcitetrol | 72203-93-1 | Calcitetrol is the hormonally active form of vitamin D with three hydroxyl groups. |
| FB09049 | Calcipotriol Monohydrate | 147657-22-5 | Calcipotriol is a synthetic VitD3 analogue with a high affinity for the vitamin D receptor. |
| FB10689 | Calcipotriol | 112965-21-6 | Calcipotriol is a synthetic VitD3 analogue with a high affinity for the vitamin D receptor. |
| FB02280 | Calcipotriol Impurity C | 113082-99-8 | Calcipotriol impurity C is the impurity of calcipotriol, a ligand of VDR-like receptors. |
| FB03860 | Calcifediol | 19356-17-3 | Calcifediol is an active metabolite of vitamin D. It can inhibit the secretion of parathyroid hormone with 2 nM and commonly used as an indicator of body vitamin D status. |
| FB00857 | Calcifediol Monohydrate | 63283-36-3 | Calcifediol is a major circulating metabolite of vitamin D3, acting as a competitive inhibitor with an apparent Ki of 3.9 μM, suppresses PTH secretion and mRNA (ED50=2 nM). |
| FB07480 | Alfacalcidol | 41294-56-8 | Alfacalcidol is a non-selective VDR activator medication. |
| FB03952 | 3-O-(2-Aminoethyl)-25-Hydroxyvitamin D3 | 163018-26-6 | 3-O-(2-Aminoethyl)-25-hydroxyvitamin D3 is a Vitamin D3 derivative. |
| FB04867 | 25,26-Dihydroxyvitamin D3 | 29261-12-9 | 25,26-Dihydroxyvitamin D3 is a metabolite of vitamin D3 with intestinal calcium transport activity. |
| FB02899 | 24, 25-Dihydroxy VD3 | 40013-87-4 | 24, 25-Dihydroxy VD3 is a compound which is closely related to 1,25-dihydroxyvitamin D3, the active form of vitamin D3, but like vitamin D3 itself and 25-hydroxyvitamin D3 is inactive as a hormone both in vitro and in vivo. |
| FB06200 | 24, 25-Dihydroxy VD2 | 58050-55-8 | 24, 25-Dihydroxy VD2 is a hydroxylated metabolite of Vitamin D2 and a synthetic analog of Vitamin D. |
| FB03206 | 1alpha-Hydroxy VD4 | 143032-85-3 | 1alpha-Hydroxy VD4 , a 1alpha (OH)D derivative, can effectively induce the differentiation of monoblastic leukaemia U937, P39/TSU and P31/FUJ cells. |
| FB05125 | 1alpha, 24, 25-Trihydroxy VD2 | 457048-34-9 | 1alpha, 24, 25-Trihydroxy VD2 is a vitamin D analog. |
| FB02277 | (24S)-MC 976 | 112849-14-6 | (24S)-MC 976 is a Vitamin D3 derivative. |
| FB06191 | (24S)-24,25-Dihydroxyvitamin D3 | 55700-58-8 | (24S)-24,25-Dihydroxyvitamin D3 is an inactive form of vitamin D3 which undergoes various levels of hydroxylation to form active vitamin D3 analogs. |
| FB02276 | (24R)-MC 976 | 112828-09-8 | (24R)-MC 976 is a Vitamin D3 derivative. |